PeptidePedia The community reference

Peptide stability table (revision 11)

Old revision·04:30, 1 Jan 2025·MarginNoteMars

This is an old revision of this page, as it stood at 04:30, 1 Jan 2025, saved by MarginNoteMars with the summary update infobox. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Peptide stability table
Rows28 compounds
ColumnsLyophilised and reconstituted storage, diluent, notes
Reference tool infobox · conventions

The peptide stability table collects reported storage conditions and stability intervals for compounds covered on this wiki. It is a navigational and comparative aid rather than a source in its own right: every figure in it is attributable to labelling or to a published study, and the two are not equivalent evidence.

Stability is a property of a formulation in a container under conditions, not of a molecule. The same peptide may carry a 36-month shelf life as a manufactured product and no meaningful stability claim at all as a lyophilised research powder in an unspecified vial, because nobody has run the study.[1] Where the table records a figure for a research compound, that figure is almost always extrapolated from a related product or from a small published study, and the notes column says so.

Compounds distributed for research are not approved for human use, and no stability figure in this table implies that any material is fit for any purpose. Sterility and endotoxin content are not stability properties and are not covered here.

The table

[edit]

Filter by compound name, or by storage class. Sorting is available on every column.

References

  1. ^ International Council for Harmonisation, Q1A(R2): Stability Testing of New Drug Substances and Products (2003).
Categories: